In a nutshell...The value of the
underlying assets, namely...
are increasing rapidly ... and will continue to do so as ....
- Tigris progresses (excrutiatingly) slowly but surely, with results that are "exceeding expectations"
- the RWE continues to mount (including hemoperfusion as a viable solution to the Sepsis and other immune over-response afflictions including possibly ARDS and Covid)
- the EDEN Study broadens the future lablel
- The FDA grants Breakthrough status (ie speeds up the endgame)
- SAMI continues to land orders and begins to ship product (validating the technology of the Infomed equipment and dialysate bags)
- the "key" DIMI useablity Trial partner is announced - indicating that an endgame for that peice is gettign closer
I see it as, although the SP is holding or rising (vs general markets), there is a growing gulf between Market Cap (
sub $ 100M USD) and underlying value (climbing from $ X Billion to $ X Billion + $ 1B or $ 2B or 3B ...)
This gulf needs to be RESOLVED...especially as one or both of the Partners (the PMX one & Da Dialco one) step up, write cheques, and in so doing begin to show their hands.
The current gulf implies that the potential Buyers of the NA Rights are privy to/entitled to more information as to value..than are the general markets and minority shareholders (who look at SP to decide "value")...Value stems from the magnitude of future revenues and EBITDA calculations for all asset categories. The gulf between what potential buyers know and or are assuming, and what many shareholders do not, cannot be allowed to get out of hand...especially as and when capital is being raised.
Time to let'er rip !
MM